This study checks if inclisiran, a medicine given by injection twice a year, can help prevent heart and limb problems. Patients who have had procedures to open blocked blood vessels, like percutaneous coronary intervention (PCI) for heart arteries or peripheral endovascular intervention (PVI) for leg arteries, might be part of this study. Placebo is a fake treatment used to compare with the real drug to see if the drug works.
About 6,000 people will join, with half receiving inclisiran and the other half a placebo. Participants will be watched over for up to four years, with check-ups every six months. The trial ends when a certain number of health events, like heart attacks, have been recorded.
- The study lasts about 4 years, depending on health events.
- Participants receive injections every 6 months.
- People with certain illnesses or treatments can't join.
How understandable was the trial content above?
Hard to understand
Easy to understand